TrumpRx launched with big promises on drug prices, but so far, it’s just 54 drugs – many with generics already cheaper elsewhere. Scale & transparency could make it useful. But now? Limited impact. Worth watching if it expands meaningfully. www.nbcnews.com/health/healt...

“Report finds hospitals price the same cancer drugs up to 2000x apart, worsening financial toxicity and intensifying demands for real transparency.” www.targetedonc.com/view/new-rep...

“A 200-milligram dose of the cancer drug Keytruda ranged from $12,000 to $43,000, the research firm found through files published under the transparency rules.” www.axios.com/2026/03/05/d...

"Drug prices are skyrocketing!" 🚀 "Drug prices are the lowest they've ever been!" 📉 Let's cut through the noise by looking at the actual numbers. Our latest: www.46brooklyn.com/news/trump-s...

You either want to fight high drug prices or you want to inflate them even more. New legislation from Senator Josh Hawley & @warren.senate.gov aims to get PBMs to pick a side. ohiocapitaljournal.com/2026/02/16/b...

Extensive discussion with Virginia Focus on new year drug price changes, rebates, the push for domestic manufacturing, TrumpRx, the Inflation Reduction Act, 340B, PBMs, and the business of pharmacy www.iheart.com/podcast/1248...

The FTC has a proposed settlement agreement with Express Scripts over allegations of artificially inflating insulin prices. Will this be the start of a new era, or will we continue to see old money harvested in new ways?

Good coverage from @loftus.bsky.social on the latest moves on brand drug list prices and how those hikes and cuts could impact patients and broader prescription drug spending www.wsj.com/health/pharm...

Brand drug list prices are on the move this month. Here’s good recent coverage of some of the latest spikes and cuts from @usatoday.com: www.usatoday.com/story/money/...

More NPR coverage of 2026 brand drug list price changes from @sydneylupkin.bsky.social: www.npr.org/2026/01/16/n...

New year, new drug prices 💊 Get a sneak peak at some of the early 2026 drugmaker list price hikes – and cuts – in an era of arguably unprecedented drug channel change. www.reuters.com/business/hea...

“Transparency can end up meaning a presentation of numbers and terms that looks detailed but still doesn't reveal what's really driving employer costs, creating an appearance of openness that protects the status quo instead of enabling real accountability.” www.benefitspro.com/2025/12/23/p...

A often-overlooked fallout of our fragmented drug distribution system: patients with too many medicines, too many prescribers, too many pharmacies, and not enough quarterbacking of the entirety of the patient’s treatment journey. www.wsj.com/health/healt...

The market won't change until employers start changing. And slowly but surely, employers are starting to change. www.healthcare-brew.com/stories/2025...

Now that Congress is back to some degree of normal business, drug pricing reforms are back in the hopper with @mikecrapo.bsky.social and @wyden.senate.gov’s long-anticipated PBM reform policy package now hitting Senate desks www.finance.senate.gov/ranking-memb...

“That sounds criminal.” Great chatting by with Paul Miller at WPHM about bloated prescription drug prices and how our reliance on conflicted intermediaries to control them can often make affordability issues even worse www.wphm.net/episode/nove...

In just a few months' time, Rite Aid and Fruth Pharmacies have been wiped off the map @martyschladen.bsky.social ohiocapitaljournal.com/2025/11/26/p...

The waves of community pharmacy closures keep coming; this time it’s my good friends over at Fruth Pharmacy. More neighborhoods of need in Ohio and West Virginia turning into pharmacy deserts. Another reminder that you get what you pay for. wchstv.com/news/local/f...

I will give you an 80% discount off the price of your cup of coffee. Sounds great, right? Let's sign a contract where all your coffee purchases go through me, and I will honor that 80% discount every time. BTW, I also set the price of that coffee.

PBMs say they want low list prices for drugs. Their new affiliated private label drug companies now have the power to do it themselves. Instead, the generic prices are on average 33 times higher than the lowest in the market. www.bloomberg.com/news/article...

Everyone says they want low drug prices until actual low drug prices show up. (except patients) @costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...

You don’t say?

From Big 3 to just zero: Rite Aid is officially reduced to ashes as pharmacy market attrition rolls on @martyschladen.bsky.social ohiocapitaljournal.com/2025/10/13/a...

“Soaking high drug prices as a mechanism to lower premiums is neither a wise nor a sustainable practice.” Acknowledge @repauchincloss.bsky.social 🎙️ www.realpharma.co/where-policy...

When Amazon makes moves in pharmacy – no matter how seemingly small – you should always be thinking about the long game @nyeungs.bsky.social endpoints.news/whats-behind...

Good news for fans of generic drug affordability 👇 www.wsj.com/health/pharm...

“American businesses should not be left to subsidize the lack of transparency, accountability and fair competition in the health care industry.” www.washingtontimes.com/news/2025/oc...

The price is the price. Unless it’s the other price. Generic drug prices are going up and down – depending on your perspective. www.46brooklyn.com/research/are...

“The immediate stock reaction across the group affirms our view this is more optics than bite.” Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social www.statnews.com/2025/09/30/w...

If you are someone who wants more drug manufacturing in the U.S., this may please you. If you are someone who wants lower brand drug prices in the U.S., this may tariffy you. www.usatoday.com/story/money/...

Look out below! www.reuters.com/business/hea...

Yeah, that’ll fix it. www.bloomberg.com/news/article...

There are 281 brand-name drugs with new list prices. Here are the details.

Another state attorney general digs into drug pricing bloat and dysfunction 👇 www.oag.state.va.us/media-center...

As a long-time fan of his show, it was awesome to join Clay Farris for a discussion about American drug pricing dysfunction. mostlymedicaid.com/medicaid-con...

When it rains, it pours.

“The current system is riddled with barriers to innovation, shielded by exclusivity protections and mired in anticompetitive practices — which help ensure high drug prices persist.” @blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...

Potential positives and negatives aside, pharm-to-table is a band-aid on a mortal wound. @aciaccia.bsky.social www.ajmc.com/view/direct-...

Behold the power of whistleblowers: $289.9 million set to come back to US government and certified G, Sarah Behnke

The policy ground is shifting on the 340B program, which means the system's current winners and losers have their eyes on how proposed changes could impact their financial realities

So essentially, the early yield of the push to bring US drug prices in line with other nations is just exporting American drug pricing distortions.

“We’re trying to disrupt an industry that needs disrupted.” Testify, Mark. @gianteagle.bsky.social @mcuban.bsky.social @costplusdrugs.com triblive.com/news/health-...

Had a great discussion with @matthewstoller.bsky.social and @ddayen.bsky.social about PBMs, pharmacies, manufacturers, Medicaid, and how misguided public policies have yielded bloated drug prices and an over-reliance on conflicted intermediaries www.organizedmoney.fm/p/the-pbm-hi...

Decades after retreating from their former marriages, PBMs are blending their DNA with drug companies once again, this time through private labelling. Here's what it means for the costs of medicines. Our latest:

It's a tough time for pharmacies, but for some, it's not all doom and gloom. If you are a PBM-affiliated pharmacy or are benefitting from 340B spreads, you are well positioned to weather the current financial storm. And if you are benefitting from both, enjoy the long ride.

Strongest signs yet that Delta Airlines could be getting into the drug business fortune.com/2025/07/16/d...

In the least surprising news ever, drugmaker financial ties with telehealth companies yields more prescriptions. Hey senators, what do you think drugmaker financial ties with formulary design yields? @davidovalle.bsky.social www.washingtonpost.com/health/2025/...

“By the end of Trump’s term, the U.S. pharmaceutical supply chain could look very different, with a greater share of innovative drug production happening on American soil. That would be a rare win-win—for the White House and for the industry.” - @davidwainer.bsky.social www.wsj.com/health/pharm...

“While the complexities of the prescription drug industry might seem ‘wonky’ to most Kentuckians, they do understand when the cost of their prescriptions increase and local pharmacies close.”

"The pharmacy’s name is more than a brand — it’s a statement." Well-timed pre-Independence Day piece on Freedom Pharmacy's shedding of PBM contracts and mission to be "the best combination of service, professionalism, and price possible in community pharmacy." 🇺🇸